NeuroRPM Joined the athenahealth Partner Community
The Parkinson's monitoring platform has launched within the athenahealth Marketplace to support clinicians.
Updated on Oct. 6, 2026 in Alzheimer’s

Live Poll
Do you trust digital health tracking tools to improve the long-term management of chronic conditions?
NeuroRPM has joined the athenahealth Partner Community, making its FDA-cleared remote monitoring platform available to providers. The software uses Apple Watch and iPhone sensors to track patient motor symptoms.
Why it matters
This integration enables clinicians to objectively monitor Parkinson's symptoms like tremor and dyskinesia between scheduled office visits. It allows providers to incorporate longitudinal patient data directly into their clinical workflows.
The athenaOne network currently connects more than 170,000 clinicians across the United States. It supports over 600 integrated solutions within its marketplace to streamline healthcare operations.
The players
NeuroRPM
NeuroRPM is a health technology company that provides an FDA-cleared remote monitoring platform for patients with Parkinson's disease.
athenahealth
athenahealth is a provider of cloud-based electronic health record and practice management software used by thousands of clinicians nationwide.
The details
The NeuroRPM platform utilizes an AI-enabled analytics engine to transform sensor data from Apple devices into quantifiable measures of motor symptoms and treatment response. Clinicians can view this objective longitudinal data within the existing athenaOne digital environment.
Timeline
October 6, 2026: NeuroRPM joined the athenahealth Partner Community.
The Big Picture
This integration follows a pattern set by the athenahealth Marketplace in allowing specialized diagnostic tools to reach a wider clinical user base. It highlights the industry trend of connecting niche monitoring technologies with major electronic health record platforms.
Patients with Parkinson's disease may experience more consistent and data-driven care as their doctors gain the ability to track symptoms remotely. This shift reduces the reliance on subjective memory during appointments and provides a clearer picture of treatment efficacy.
The takeaway
Patients should discuss with their neurologists whether remote monitoring tools can be integrated into their current treatment plan. Using wearable technology to track daily symptoms can lead to more precise medication adjustments and better overall disease management.
Further reading
For more information on similar neurological condition management tools, visit the Alzheimer’s section.
Live Poll
Do you trust digital health tracking tools to improve the long-term management of chronic conditions?










